Herba Chemosan nun österreichisch: Management Buy-Out erfolgreich abgeschlossen
Vorstand der Herba Chemosan Unternehmensgruppe gemeinsam mit Invest AG der Raiffeisenbankengruppe OÖ nun Eigentümer des…
Ribbon Biolabs Raises EUR 18 Million Series A Financing Enabling Commercial Scale Production Facilities and US Expansion for DNA Synthesis Technology
Ribbon Biolabs, the DNA synthesis company, today announced the successful close of EUR 18 million in its Series A…
AFFiRiS and Frontier Biotechnologies announce license agreement for AFFITOPE® AT04, an active immunotherapy targeting PCSK9 to treat hypercholesterolemia, in Greater China
Frontier Biotechnologies obtains exclusive rights to develop and commercialize AFFITOPE® AT04 in Greater…
Center for Precision Medicine at MedUni’s Vienna General Hospital Campus to be named after Nobel Prize winner Eric Kandel
Funded by the European Resilience and Recovery Facility as well as donations, the Center for Precision Medicine (CPM) is…
HealthTech startup myReha raises 2.2 million euros before product launch
The company develops digital stroke rehab that can help 20,000 people in Austria each year.
Sanofi to acquire Origimm Biotechnology in first move to treat acne with vaccine-based immunotherapy
- Origimm brings expertise in antigen discovery for immune modulation of skin microbiome-associated disorder
-…
OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF
OncoOne, a biotechnology company focused on discovering precision medicines for cancer and other indications and…
BioNTech to acquire PhagoMed
BioNTech announces third quarter 2021 financial results and corporate update
Für mehr Versorgungssicherheit: AOP Orphan nimmt Verpackungsanlage in Wien in Betrieb
Sieben Medikamente verpackt AOP Orphan ab 2022 am Standort Wien selbst. Damit steigt die Versorgungssicherheit bei…
Spatenstich für HOOKIPA-Produktionsstandort in aspern Die Seestadt Wiens
- Mit der Errichtung der Produktionsanlage PLANT des Biotech-Unternehmens werden im Vollbetrieb bis zu 100 neue…
Boehringer Ingelheim inaugurates biopharmaceutical production facility in Vienna, Austria
- Adds 185,000 litres of biopharmaceutical production capacity
- High degree of digitalization and automation through…
Austrian AOP Orphan to Tap into U.S. Market with Partner Eagle Pharmaceuticals
European rare and special disease pioneer AOP Orphan Pharmaceuticals GmbH has entered into a licensing agreement with…